The supply of the Johnson & Johnson coronavirus vaccine is set for a big boost, as its fierce competitor, Merck & Co., has agreed to help produce the shots.

Under the deal, to be announced later Tuesday by President Biden, one Merck facility in the United States will manufacture the vaccine, while a second facility will package it.

Recommended Stories

Public confidence in Johnson & Johnson vaccine plummets after FDA pause, polling shows

Omicron fears boosting vaccinations

FDA greenlights Pfizer vaccine boosters for 16- and 17-year-olds